about
Depressive symptoms in neurodegenerative diseasesDopamine Agonists and their risk to induce psychotic episodes in Parkinson's disease: a case-control study.Use of latent variable modeling to delineate psychiatric and cognitive profiles in Parkinson disease.Course of psychiatric symptoms and global cognition in early Parkinson disease.Depression in Parkinson's disease: symptom improvement and residual symptoms after acute pharmacologic management.Clinical aspects of palliative care in advanced Parkinson's disease.Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson's disease.Geriatric depression and cognitive impairment.Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis.Assessing depression and factors possibly associated with depression during the course of Parkinson's disease.Prevalence of psychotic symptoms in a community-based Parkinson disease sampleCognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial.Differences in depression symptoms in patients with Alzheimer's and Parkinson's diseases: evidence from the 15-item Geriatric Depression Scale (GDS-15)Suicidal and death ideation in Parkinson's disease.Attitudes regarding the etiology and treatment of depression in Parkinson's disease: a qualitative study.Prevalence of depression among older Americans: the Aging, Demographics and Memory Study.Mitochondrial dynamics in Parkinson's disease.Transcranial direct current stimulation and repetitive transcranial magnetic stimulation in consultation-liaison psychiatry.Neuropsychiatric symptoms in untreated Parkinson's disease.A Novel Approach to Treating Anxiety and Enhancing Executive Skills in an Older Adult with Parkinson's Disease.Clinically significant psychiatric symptoms among male carriers of the fragile X premutation, with and without FXTAS, and the mediating influence of executive functioning
P2860
Q26798063-53B2DAF7-6C67-468F-85E9-0839591FE76FQ33465315-7451B840-6F14-4938-8AD2-FFB4FE98C9C3Q33767361-375B8F9E-2748-4D50-A1BC-162CA42FE723Q34198761-6911AEB8-C4FA-4D2C-BFBE-9DC9470CA9EDQ34442089-23DED45B-E02B-4AB2-AF42-DA407C92F02AQ34457767-F20F22D1-362C-4120-8C19-8BEC3FB5BE1EQ34576574-3F85223D-ADBD-40BD-B7B8-2489676DB505Q34641123-5E4CA7A9-FF2C-473F-8094-008ECF263865Q34660675-2A304BCE-F72D-4E7E-8395-5993F465E248Q35189606-35C4274B-85CE-4286-B9BB-4CAC08C805F1Q35201060-7189412C-FA78-4AF7-B5F4-D3613B5663DCQ35269306-FBF789C6-F12D-49EB-8F50-DFA50DB8D6ACQ36158448-69778B34-8284-43C8-817A-9ECEB2AD3084Q37084012-D8F8383E-1264-417C-9B0E-8156603BCE7BQ37187592-D6CDF173-DB3F-48CF-AE08-48CA4F6F2B6BQ37354604-9426F5B1-AD88-42B6-B428-32398D7E483FQ37364337-31AED0AC-7153-425C-8983-C9E6F59E0411Q37371215-0C3656A4-7319-44C2-A397-C59C8C7CCD0AQ37714081-F20FE66A-2565-45FD-807C-01509FB6E7F4Q40099576-200DC094-54F2-493C-8678-032BFEB68F43Q41017873-5E5A26BB-4DC2-4708-BE7B-4C2B298B83B2
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Psychiatric complications in Parkinson disease.
@ast
Psychiatric complications in Parkinson disease.
@en
type
label
Psychiatric complications in Parkinson disease.
@ast
Psychiatric complications in Parkinson disease.
@en
prefLabel
Psychiatric complications in Parkinson disease.
@ast
Psychiatric complications in Parkinson disease.
@en
P1476
Psychiatric complications in Parkinson disease.
@en
P2093
Matthew B Stern
P304
P356
10.1176/APPI.AJGP.13.10.844
P577
2005-10-01T00:00:00Z